Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone

European Journal of Dermatology

Volumn 9, Issue 2, 1999, Pages 111-114

  Freyschmidt Paul, Pia ^a   Hamm, Henning ^b   Happle, Rudolf ^a   Hoffmann, Rolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Alopecia areata; Diphencyprone; Immunotherapy; Perifollicular lymphocytic infiltrate

Indexed keywords

DIPHENCYPRONE;

ALOPECIA AREATA; ARTICLE; BIOPSY; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; PROGNOSIS; SCALP; SKIN FIBROSIS; TOPICAL DRUG ADMINISTRATION;

EID: 0032899233     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Happle R, Echtemacht K. Induction of hair growth in alopecia areata with DNCB. Lancet 1977; ii: 1002-3.
2. Happle R, Cebulla K, Echternacht-Happle K. Dinitrochlorobenzene therapy for alopecia areata. Arch Dermatol 1978; 114: 1629-31.
3. Happle K. DNCB-Therapie der Alopecia areata. Z Hautkr 1979; 54:426-9.
4. Happle R, Kalveram KJ, Büchner U, Echternacht-Happle K, Göggelmann W, Summer KH. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Dermatologica 1980; 161: 289-97.
5. Friedmann PS. Dinitrocholorobenzene and alopecia (letter). Lancet 1979; i: 1412.
6. Friedmann PS. Response of alopecia areata to DNCB: influence of auto-antibodies and route of sensitization. Br J Dermatol 1981; 105: 285-9.
7. Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT. Topical immunotherapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol 1984; 10: 447-51.
8. Van der Steen PHM, van Baar HMJ, Happle R, Boezeman JBM, Perret CM. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991; 24: 227-30.
9. Van der Steen PHM, Boezeman JBM, Happle R. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow- up period of 19 months. Dermatology 1992; 184: 198-201.
10. Weise K, Kretzschmar L, John SM, Hamm H. Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 1996; 192: 129-33.
11. Breuillard F. Dinitrochlorobenzene in alopecia areata (letter). Lancet 1978; ii: 1304.
12. De Prost Y, Paquez F, Touraine R. Dinitrochlorobenzene treatment of alopecia areata. Arch Dermatol 1982; 118: 542-5.
13. Temmermann L, De Weert J, De Keyser L, Kint A. Treatment of alopecia areata with dinitrochlorobenzene, Acta Derm Venereol (Stockh) 1984; 64: 441-4.
14. Ochsendorf FR, Mitrou G, Milbradt R. Therapie der Alopecia areata mit Diphenylcyclopropenon. Z Hautkr 1988; 63: 94-100.
15. Gordon PM, Aldridge RD, McVittie E, Hunter JAA. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow- up. Br J Dermatol 1996; 134: 869-71.
16. Fanti PA, Tosti A, Bardazzi F, Guerra L, Morelli R, Cameli N. Alopecia areata: a pathological study of non responder patients. Am J Dermotopathol 1994; 16: 167-70.
17. Uno H, Orecchia G. Histopathology of alopecia areata: the relation with clinical parameters and response to a topical sensitizer. In: Van Neste D, Lachapelle JM, Antonie JL, eds. Trends in Human Hair Research and Alopecia Research. Kluwer Academic Publishers, Dordrecht 1989: 273-81.
18. Headington JT. The histopathology of alopecia areata. J Invest Dermatol 1991; 96 (suppl.): 69S.
19. Goos M. Zur Histopathologie der Alopecia areata. Arch Dermatol forsch 1971; 240: 160-72.
20. Ackerman AB. Alopecia areata. In: Ackerman AB, Ragaz A, eds. The Lives of Lesions: Chronology in Dermatopathology. Masson Publishing USA, Inc, 1984: 13-9.
21. Messenger AG, Slater DN, Bleehen SS. Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology. Br J Dermatol 1986; 114: 337-47.